The American journal of tropical medicine and hygiene · 2022
Clinico-Epidemiologic Characteristics of Patients Reported in the Mycotic Infections in COVID-19 Registry.
СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Maini Rohan, Saini Neha, Bhavana Kranti, Bharti Bhartendu, Walia Shweta, Kori Neetu, Kataria Sushila, Sharma Pooja, Deswal Vikas, Atluri Kavya, Sethi Yatin, Mandke Charuta, Chansoria Mayank, Rawat Sumit, Bhat Rajani, Dravid Ameet, Baranwal Chandan, Sarkar Nirmal, Jariwala Sunit, Puius Yoram, Arora Shitij, MUNCO Registry
Аннотация
We update results from the Mycotic Infections in COVID-19 (MUNCO) Registry, May-September 2021. Data collection from May to September 2021 yielded 728 cases from India, Nepal, Bangladesh, Thailand, and the United States. The cases consisted of mostly mucormycosis (97.6%), primarily rhinocerebral, and were analyzed to investigate clinical characteristics associated with negative outcomes. Patients were mostly diabetic (85%) and male (76%), with significant mortality (11.7%). All patients received treatment of coronavirus disease 2019 (COVID-19) as well as antifungal treatment. The crude mortality rate was 11.3% for mucormycosis and 22.7% formixed infections. This study demonstrates the utility of online databases in the collection of high-caliber data.